| |APRIL 202619or the effectiveness of collagen peptide supplementation, ultimately mitigating inflammatory cartilage destruction. UDCORE-ii is supplied only as a formulated or finished product.Collectively, NESM and UDCORE-ii integrate biomaterial science, translational biotechnology, and evidence-based nutraceutical research, providing mechanism-driven, safety-oriented solutions for osteoarthritis and musculoskeletal health. Moreover, patented stabilization and production processes, clinical validation, and regulatory approvals differentiate these ingredients in today's competitive market, offering high-performance alternatives that shift the paradigm from symptomatic pharmacotherapy toward structural joint support and long-term functional resilience.Engineered for ExcellenceMicrocore combines precision manufacturing with rigorous R&D to deliver reproducible, high-quality nutraceuticals. The company treats production as a scientifically governed, compliance-driven system, ensuring consistent efficacy across batches. Its infrastructure and certifications include GMP, ISO 22000 with HACCP-based risk management, and FSSAI compliance. Structured production protocols, validated equipment, environmental controls, SOPs, and traceability effectively eliminate variability, while advanced quality control encompasses active marker quantification, stability testing, microbiological profiling, and contaminant analysis. Notably, raw materials undergo rigorous vendor qualification, identity verification, and marker-based standardization. Finished formulations are later subjected to assay verification, dissolution or disintegration testing, stability validation, and issuance of Certificates of Analysis.Regulatory compliance spans Batch Manufacturing Records, Batch Packaging Records, full traceability, deviation management, CAPA systems, change control protocols, recall preparedness, and audit-ready documentation, ensuring accountability and reliability throughout the production process.With respect to its R&D capabilities, the company underpins manufacturing excellence, combining ingredient innovation, process engineering, analytical validation, and clinically aligned formulation design. Its DSIR-recognized infrastructure and advanced laboratories develop standardized bioactive ingredients through proprietary extraction, purification, and stabilization technologies.Patented processes and trademarked branded bio-actives ensure intellectual property ownership and differentiation. Clinical validation further strengthens credibility through well-designed human studies, mechanistic evaluations, and peer-reviewed publications that substantiate safety, bioavailability, and efficacy. Advanced formulation technologies, including molecular interlocking and nano-preparation systems, enhance bioavailability, enable controlled release, and optimize therapeutic performance, translating scientific concepts into measurable clinical benefits. This integrated approach ensures that every nutraceutical produced by Microcore is scientifically substantiated, reliably manufactured, and performance-driven.The Map for the FutureMicrocore continues to expand proprietary platforms, including NESM, Natural Egg Shell Calcium (NESC), undenatured Type II collagen, eggshell-derived hydroxyapatite, and molecular interlocking biomaterial technologies. With advanced R&D facilities in Tamil Nadu and a 10-acre integrated innovation hub under development, the company offers a fully indigenous, end-to-end biomaterial ecosystem, spanning raw material engineering, molecular stabilization, clinical validation, and commercialization.Emphasizing research-intensive growth, Microcore reinvests revenue into fundamental and applied research. "We aim to start a Made-in-India renaissance, developing high-value bioactive molecules domestically, reducing import dependence, enhancing indigenous manufacturing, and expanding global export potential," states M. Chandramohan, Founder at Microcore. By integrating innovation, clinical validation, and commercialization, Microcore aims to transform cutting-edge research into a sustainable engine of differentiation, impact, and national scientific leadership. Microcore's future focus is on expanding medical applications of natural eggshell membrane, undenatured type II collagen, and egg-derived calcite through advanced research and clinical validation. These bioactive biomaterials show strong potential in wound healing, gastroenteritis management, and skin grafting, supporting tissue repair, inflammation control, and regenerative processes. Through collaborations with medical research institutions, Microcore aims to translate these natural biomaterials into clinically relevant solutions for several medical procedures. PO
< Page 9 | Page 11 >